Phase I study of green tea extract in patients with advanced lung cancer Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Small Cell
  • Lung Neoplasms
  • Tea

abstract

  • This study suggests that while relatively nontoxic at a dose of 3 g/m2 per day, GTE likely has limited activity as a cytotoxic agent, and further study of GTE as a single-agent in established malignancies may not be warranted. Further studies should focus on the potential chemopreventive and chemotherapy-enhancing properties of GTE.

publication date

  • January 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s00280-004-0859-1

PubMed ID

  • 15309507

Additional Document Info

start page

  • 33

end page

  • 8

volume

  • 55

number

  • 1